PTP1B Antibodies

Santa Cruz Biotechnology features a diverse variety of PTP1B monoclonal antibodies for research focused on understanding Protein Tyrosine Phosphatase 1B (PTP1B) in various biological processes. PTP1B monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PTP1B is a critical enzyme involved in the regulation of insulin signaling and plays a significant role in glucose homeostasis. Dysregulation of PTP1B has been implicated in metabolic disorders, including obesity and type 2 diabetes, making it a key target for therapeutic intervention. Research utilizing PTP1B monoclonal antibodies can provide valuable insights into the mechanisms underlying these conditions. PTP1B monoclonal antibodies enable researchers to investigate cellular signaling pathways with precision and reliability. Studying PTP1B expression patterns and interactions helps advance understanding of metabolic regulation and potential therapeutic strategies. Research conducted with Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific knowledge in metabolic disease research and therapeutic development.